Deborah Elman is a director at Grant & Eisenhofer, where she has nearly two decades’ experience representing both plaintiffs and defendants in high-profile antitrust and securities litigation. Ms. Elman’s practice focuses on litigating claims in the pharmaceutical and financial services industries. She has represented institutional clients and individuals in complex civil litigation cases, including class actions, opt-outs, derivative actions, and arbitrations. Ms. Elman is also Co-Director of the Grant & Eisenhofer ESG Institute.
Currently, Ms. Elman is representing a class of silver purchasers in In re London Silver Fixing, Ltd. Antitrust Litigation; a class of merchants in In re Payment Card Interchange Fee & Merchant Discount Antitrust Litigation; a class of end-payor purchasers in In re Seroquel XR (Extended Release Quetiapine Fumarate) Litigation; and direct purchaser plaintiffs in In re Keurig Green Mountain Single-Serve Coffee Antitrust Litigation. She is a member of the leadership team representing clients in In re Humira (Adalimumab) Antitrust Litigation, and class counsel in In re Novartis and Par Antitrust Litigation [Exforge].
Ms. Elman was class counsel in Alaska Electrical Pension Fund v. Bank of America Corporation et al. (“ISDAFix”) and In re Foreign Exchange Benchmark Rates Antitrust Litigation (“FOREX”), and litigated and settled numerous cases related to the financial crisis, including more than fifteen actions arising out of wrongdoing involving the issuance of residential mortgage-backed securities (“RMBS”) and other complex financial products. Additionally, Ms. Elman was a member of the litigation teams that successfully represented the lead plaintiff in a case dubbed “The Enron of India,” In re Satyam Computer Services Ltd. Securities Litigation, which settled for $150.5 million, and In re Kinder Morgan Energy Partners, L.P. Derivative Litigation, which settled for $27.5 million. She represented institutional investors in In re Merck and Co., Inc. Securities, Derivative & ERISA Litigation and In re Petrobras Securities Litigation, resulting in substantial investor recoveries.
Ms. Elman is Vice Chair of the Pricing Conduct Committee of the American Bar Association Antitrust Law Section, and a member of the Amicus Committee for the Committee to Support the Antitrust Laws, the Coordinated Conduct Committee of the New York State Bar Association Antitrust Section, and the Board of Directors of the Public Justice Foundation.
Prior to joining Grant & Eisenhofer, Ms. Elman represented clients before the SEC, DOJ, and state regulators, and appeared before federal and state courts as an associate at a leading New York law firm.